Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 3 drugs with upcoming expirations
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Xadago — XADAGO
Application NDA207145
Adrenaline — EPINEPHRINE
Application NDA209359 (NDA)
Bronkaid Mist — EPINEPHRINE
Application NDA209359 (NDA)
Kynmobi — KYNMOBI
Application NDA210875 (NDA)
Kynmobi — KYNMOBI
Application NDA210875 (NDA)
Xadago — XADAGO
Application NDA207145
Adrenaline — EPINEPHRINE
Application NDA211363 (NDA)
Bronkaid Mist — EPINEPHRINE
Application NDA211363 (NDA)
Adrenaline — ADRENALIN
Application NDA215875 (NDA)
Bronkaid Mist — ADRENALIN
Application NDA215875 (NDA)
Adrenaline — EPINEPHRINE
Application NDA205029 (NDA)
Bronkaid Mist — EPINEPHRINE
Application NDA205029 (NDA)
Adrenaline — EPINEPHRINE
Application NDA215425 (NDA)
Bronkaid Mist — EPINEPHRINE
Application NDA215425 (NDA)
Adrenaline — NEFFY
Application NDA214697 (NDA)
Bronkaid Mist — NEFFY
Application NDA214697 (NDA)
Kynmobi — ONAPGO
Application NDA214056 (NDA)
Kynmobi — ONAPGO
Application NDA214056 (NDA)
Adrenaline — EPINEPHRINE
Application NDA220626 (NDA)
Bronkaid Mist — EPINEPHRINE
Application NDA220626 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)